Description
Product Characteristics:
Aliases: 4 N-acetylgalactosaminyltransferase 2 antibody, 4-GalNAc transferase antibody, 4-N-acetylgalactosaminyltransferase antibody, B4GALNT2 antibody, B4GALT antibody, B4GN2_HUMAN antibody, Beta 1,4 N-acetylgalactosaminyltransferase/betal,4 GalNAcT/Sda-GalNAcT antibody, Beta-1 antibody, beta-1,4-N-acetyl-galactosaminyl transferase 2 antibody, beta-4-N-acetylgalactosaminyltransferase antibody, CT-GalNAc transferase antibody, GALGT2 antibody, Sd(a) beta-1 antibody, sda beta-1,4-GalNAc transferase antibody, UDP-GalNAc:Neu5Aca2-3Galb-R b1 antibody, UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase antibody, UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase antibody
Target Information: B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).[supplied by OMIM, Mar 2008]